|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1996-2-1
|
|
pubmed:abstractText |
To assess the lipid-lowering effect of atorvastatin (a new 3-hydroxy-3-methylglutaryl coenzyme A [HMG-CoA] reductase inhibitor) on levels of serum triglycerides and other lipoprotein fractions in patients with primary hypertriglyceridemia, determine if atorvastatin causes a redistribution of triglycerides in various lipoprotein fractions, and assess its safety by reporting adverse events and clinical laboratory measurements.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0098-7484
|
|
pubmed:author |
pubmed-author:Bakker-ArkemaR GRG,
pubmed-author:BlackD MDM,
pubmed-author:BrownW VWV,
pubmed-author:DavidsonM HMH,
pubmed-author:DavignonJJ,
pubmed-author:GoldsteinR JRJ,
pubmed-author:IsaacsohnJ LJL,
pubmed-author:KeilsonL MLM,
pubmed-author:MillerV TVT,
pubmed-author:ShurzinskeL JLJ,
pubmed-author:WeissS RSR
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
10
|
|
pubmed:volume |
275
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
128-33
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8531308-Adult,
pubmed-meshheading:8531308-Aged,
pubmed-meshheading:8531308-Analysis of Variance,
pubmed-meshheading:8531308-Anticholesteremic Agents,
pubmed-meshheading:8531308-Diet, Fat-Restricted,
pubmed-meshheading:8531308-Dose-Response Relationship, Drug,
pubmed-meshheading:8531308-Double-Blind Method,
pubmed-meshheading:8531308-Enzyme Inhibitors,
pubmed-meshheading:8531308-Female,
pubmed-meshheading:8531308-Heptanoic Acids,
pubmed-meshheading:8531308-Humans,
pubmed-meshheading:8531308-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:8531308-Hypertriglyceridemia,
pubmed-meshheading:8531308-Linear Models,
pubmed-meshheading:8531308-Lipoproteins,
pubmed-meshheading:8531308-Male,
pubmed-meshheading:8531308-Middle Aged,
pubmed-meshheading:8531308-Pyrroles,
pubmed-meshheading:8531308-Triglycerides
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia.
|
|
pubmed:affiliation |
Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, Mich 48105-1047, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
